Collectively, these genetic alterations suggest that GMR-AML1 cell line is derived from the clonal expansion under in vitro culture conditions of AML stem-progenitor cells present in the BMA of the patient with FPD-MM. Here, RUNX1 is linked to acute myeloid leukemia.